CapsoVision, Inc. Common Stock (CV) Stock
NASDAQ · CV
Key stats
- Market cap
- $333.63M
- Price / Earnings ratio
- -10.7x
- EPS (TTM)
- -$0.45
- Volume
- Loading
- 52-week high
- $15.37
- 52-week low
- $4.50
Source: third-party data provider, as of November 13, 2026
Compare with CV
Recent news

MarketBeat
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
PositiveCVOctober 24, 2026
MarketBeatPositive
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
CV

MarketBeat
CapsoVision Q2 Earnings Call Highlights
CVAugust 13, 2026
MarketBeat
CapsoVision Q2 Earnings Call Highlights
CV

MarketBeat
CapsoVision Q1 Earnings Call Highlights
CVMay 14, 2026
MarketBeat
CapsoVision Q1 Earnings Call Highlights
CV

Zacks Investment Research
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CVJanuary 2, 2026
Zacks Investment Research
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CV
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 42.25
- MACD 12/26/9
- -0.05
- EMA 9 of MACD
- 0.02
- MACD histogram
- -0.07
- SMA 50
- $6.52
- Price below SMA 50
- EMA 50
- $6.56
- Price below EMA 50
- SMA 200
- $6.37
- Price below SMA 200
- EMA 200
- $6.68
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Revenue
Net income
Net margin %
2023
2024
2025
16M11M5M0
Debt & Balance Sheet
Total assets
Total liabilities
2023
2024
2025
26M17M9M0
Revenue to Profit
2025$13.6M
Revenue$0.0
Cost of revenue$7.2M
Gross profit$0.0
Operating expenses$-25.3M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

MarketBeat
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
PositiveCVOctober 24, 2026
MarketBeatPositive
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
CV

MarketBeat
CapsoVision Q2 Earnings Call Highlights
CVAugust 13, 2026
MarketBeat
CapsoVision Q2 Earnings Call Highlights
CV

MarketBeat
CapsoVision Q1 Earnings Call Highlights
CVMay 14, 2026
MarketBeat
CapsoVision Q1 Earnings Call Highlights
CV

Zacks Investment Research
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CVJanuary 2, 2026
Zacks Investment Research
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CV
News tone: automated (AI) classification of the article's content, not a price prediction.
About CapsoVision, Inc. Common Stock
No description available.
SectorHealthcare
IndustryMedical Devices
Employees99
CEOMr. Kang-Huai Wang
IPO DateJul 2, 2025
HeadquartersSaratoga, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kang-Huai Wang | Co-Founder, President, CEO & Director | 1957 |
| Mr. David Garcia | Compliance Officer, SVP of Finance, Principal Financial & Accounting Officer | 1975 |
| Mr. Douglas Atkinson | Senior Vice President of Global Sales | 1968 |
| Helen Chau | Manager of Human Resources | — |
| Anna Krylova | Corporate Controller | — |
Fundamentals
Valuation
Price-to-sales ratio25.47
Price-to-book value24.21
Profitability
Return on Equity-178.00%
Return on Assets-135.00%
Return on Sales-215.00%
Gross margin (latest quarter)51.36%
EBITDA$-29.21M
Trading
Average volume129,633
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 42.25
- MACD 12/26/9
- -0.05
- EMA 9 of MACD
- 0.02
- MACD histogram
- -0.07
- SMA 50
- $6.52
- Price below SMA 50
- EMA 50
- $6.56
- Price below EMA 50
- SMA 200
- $6.37
- Price below SMA 200
- EMA 200
- $6.68
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +10.6 | -4.1 | +32.6 | +3.8 | +16.9 | +91.6 | ||||||
| 2026 | -51.0 | +0.4 | +35.3 | +6.5 | -9.6 | +9.9 | -10.7 | -18.5 | +10.1 | +8.1 | -6.8 |
Compare stocks
Market cap
$333.63M
-
-
-
Price / Earnings ratio
-10.70
-
-
-
Price / Sales ratio
25.47
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
129,633
-
-
-
Earnings per share
$-0.45
-
-
-



